Our vision
To position the North East as a leader in the development, testing, manufacturing and adoption of people-centred treatments, therapeutics and medicines at a time of demographic change.
Our objectives
By 2030, we will have:
- Doubled the number of businesses active in the health and life sciences community in the region from 150 to 300
- Doubled the number of jobs in the health, life sciences and pharmaceuticals businesses and the research and development community in the region from 12,000 to 24,00
What the evidence tells us
£1.7bn
In 2019, health and life sciences in the North East region had a turnover of £1.7bn
1,400
(From 2010-2019)
This represents an equivalent increase of: 22% Compared nationally: 9%
Opportunities
- Growth and modernisation of manufacturing and the supply chain
- Development of new services and treatments
- Collaboration with the NHS to adopt and commercialise drugs and treatments
- Inward investment
- Growth and investment in life sciences SMEs
- Strengthening our cluster and networks
Challenges
- Overall size of the economy
- Brand and awareness
- Connectivity
- Aspects of the business environment
The Strategy
New – Career Pathways for roles in high demand
Read our Health, life sciences and medicines manufacturing: A growth strategy for the North East
Find out more about our framework to deliver the skills that the sector needs to grow.